Abstract
The incidence of novel coronavirus disease-19 (nCoV-19) and its associated complications is higher in high-risk groups. In this article, we explain the symptoms and course of the disease and the treatment for an adult patient with CHD who has been infected with novel nCoV-19.
Keywords:
Adult CHD; SARS-CoV-2; tetralogy of Fallot.
MeSH terms
-
Angiotensin-Converting Enzyme Inhibitors / administration & dosage
-
Betacoronavirus / isolation & purification
-
COVID-19
-
Cardiomegaly* / diagnosis
-
Cardiomegaly* / etiology
-
Comorbidity
-
Coronavirus Infections* / diagnosis
-
Coronavirus Infections* / physiopathology
-
Coronavirus Infections* / therapy
-
Cyanosis* / diagnosis
-
Cyanosis* / etiology
-
Diagnosis, Differential
-
Diuretics / administration & dosage
-
Echocardiography / methods*
-
Electrocardiography / methods
-
Humans
-
Lung / diagnostic imaging*
-
Male
-
Middle Aged
-
Oximetry / methods
-
Oxygen Inhalation Therapy / methods
-
Pandemics*
-
Pneumonia, Viral* / diagnosis
-
Pneumonia, Viral* / physiopathology
-
Pneumonia, Viral* / therapy
-
SARS-CoV-2
-
Tetralogy of Fallot* / diagnosis
-
Tetralogy of Fallot* / physiopathology
-
Tetralogy of Fallot* / therapy
-
Tomography, X-Ray Computed / methods
-
Treatment Outcome
Substances
-
Angiotensin-Converting Enzyme Inhibitors
-
Diuretics